TJ Therapeutics Deal History & Licensing Activity
TJ Therapeutics is a life sciences. Over the past three years, TJ Therapeutics has been involved in 3 licensing and acquisition transactions, with a primary focus on Antibodies (6 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Antibodies
Focus Area
Mega Deals
TJ Therapeutics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving TJ Therapeutics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| felzartamab | Biogen | Antibodies | Unknown | license | Apr 2026 |
| felzartamab | Biogen | Antibodies | Unknown | license | Apr 2026 |
| felzartamab | Biogen | Antibodies | Phase 2 | license | Apr 2026 |
TJ Therapeutics Pipeline Focus
Therapeutic areas and modalities where TJ Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches TJ Therapeutics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About TJ Therapeutics Licensing & Deal Activity
TJ Therapeutics is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, TJ Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for TJ Therapeutics include Mega Deals (6 deals and trials). In terms of modality, TJ Therapeutics has shown particular interest in antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for TJ Therapeutics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against TJ Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.